Co-investigator on GSBTM funded major research project titled “Therapeutic Targeting of Androgen Receptor as a biomarker to improve the clinical outcomes of Triple-Negative Breast Cancer” worth 44,14,856/-. (Project duration: 28/12/2021 to 27/12/2024).

Admissions to the University are strictly based on merit and in accordance with approved policies and procedures.

No individual within or outside the University, nor any agent or agency, is authorized to influence admission decisions in exchange for money, favors, or any other consideration. Applicants and parents are strongly advised not to entertain or respond to any such appeals.

If you receive any communication seeking payment or promising admission, please report it immediately to:

The University will not be responsible for any unauthorized payments made and involvement in such acts may lead to cancellation of admission.